Atlas Trials

Suzhou Abogen Biosciences Co., Ltd.

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Suzhou Abogen Biosciences Co., Ltd.

RecordFirmDate
An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors (NCT07583953)Suzhou Abogen Biosciences Co., Ltd.2026-04-17
Phase II Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above (NCT07285278)Suzhou Abogen Biosciences Co., Ltd.2025-11-15
Phase II Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 50 Years or Above (NCT07289542)Suzhou Abogen Biosciences Co., Ltd.2025-09-15
Phase I Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above (NCT07285265)Suzhou Abogen Biosciences Co., Ltd.2025-05-27
Phase I Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 18 Years or Above (NCT07289503)Suzhou Abogen Biosciences Co., Ltd.2025-05-27
Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors (NCT06088004)Suzhou Abogen Biosciences Co., Ltd.2023-09-28
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SARS-CoV-2 Variant (BA.4 /5) mRNA Vaccine (NCT05636319)Suzhou Abogen Biosciences Co., Ltd.2022-11-23
A Study to Evaluate Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19) mRNA Vaccines (NCT05434585)Suzhou Abogen Biosciences Co., Ltd.2022-07-08

Track Suzhou Abogen Biosciences Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.